A 65-year-old man with type 2 diabetes and prior myocardial infarction is on ramipril, metoprolol, atorvastatin, and low-dose aspirin. HbA1c is 7.1%. ...

Question

A 65-year-old man with type 2 diabetes and prior myocardial infarction is on ramipril, metoprolol, atorvastatin, and low-dose aspirin. HbA1c is 7.1%. According to Diabetes Canada cardiovascular risk reduction recommendations, which additional class of medication should be considered?

Accepted Answer

SGLT2 inhibitor or GLP-1 receptor agonist with proven CV benefit

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Answer

Alpha-glucosidase inhibitor

Answer

No additional therapy is recommended

ca-mccqe1 MCQ (SBA): Cardiovascular risk reduction in diabetes

A 65-year-old man with type 2 diabetes and prior myocardial infarction is on ramipril, metoprolol, atorvastatin, and low-dose aspirin. HbA1c is 7.1%. According to Diabetes Canada cardiovascular risk reduction recommendations, which additional class of medication should be considered?